Results 271 to 280 of about 703,659 (314)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Sang thrombose vaisseaux, 2021
La prescription d’un traitement doit reposer autant que possible sur des donnees factuelles. Pour ce faire, le prescripteur peut s’appuyer sur les essais therapeutiques a condition qu’il en ait verifie la qualite methodologique garante de la validite interne. Celle-ci repose principalement sur le caractere controle et randomise de l’etude.
Laura Mechtouff, Pierre Durieux
openaire +1 more source
La prescription d’un traitement doit reposer autant que possible sur des donnees factuelles. Pour ce faire, le prescripteur peut s’appuyer sur les essais therapeutiques a condition qu’il en ait verifie la qualite methodologique garante de la validite interne. Celle-ci repose principalement sur le caractere controle et randomise de l’etude.
Laura Mechtouff, Pierre Durieux
openaire +1 more source
Cephalalgia, 2000
The author reflects on the growing use of and acclaim for RCTs as a method for policy discovery. The chapter outlines the social science thinking behind the tool, provide some examples of its use and then discuss its strengths and weaknesses.
openaire +1 more source
The author reflects on the growing use of and acclaim for RCTs as a method for policy discovery. The chapter outlines the social science thinking behind the tool, provide some examples of its use and then discuss its strengths and weaknesses.
openaire +1 more source
The Internet and randomised controlled trials
International Journal of Medical Informatics, 1997Several factors constrain the implementation of Randomised Controlled Trials (RCTs). To obtain large sample sizes a multicentred multinational trial may be necessary or a long sampling period. The larger the trial the larger is the unit cost. To allow larger sample sizes, shorter sampling periods and lower unit costs, new methods are needed.
M A, Kelly, J, Oldham
openaire +2 more sources
British Journal of Midwifery, 2017
In 2005, Sir Ian Wilmut said we shouldn't await more evidence before offering stem cell treatments to terminal patients. George Winter challenges attitudes concerning the universal necessity of RCTs
openaire +2 more sources
In 2005, Sir Ian Wilmut said we shouldn't await more evidence before offering stem cell treatments to terminal patients. George Winter challenges attitudes concerning the universal necessity of RCTs
openaire +2 more sources
The randomised controlled trial: a critique
Nurse Researcher, 1998Traditionally, health care has been based on historical legacy, personal treatment preferences and ritual. Indeed in the present day, some health professionals persist not only in practising clinical interventions that are known to be ineffective, but also fail to introduce others that tire known to have good outcomes, resulting in inescapably huge ...
openaire +2 more sources
Huisarts en wetenschap, 2013
56 (8) augus t us 2013 Bij een goede RCT weet de patient van tevoren niet of hij in de interventiegroep of de controlegroep terecht zal komen (blindering) en wordt dit ‘blind’ toegewezen (concealed allocation). Patient, behandelend arts en degene die het resultaat van de behandeling beoordeelt, blijven idealiter ook gedurende het hele onderzoek ...
De Jong, Jip, Van Dijk, Nynke
openaire +1 more source
56 (8) augus t us 2013 Bij een goede RCT weet de patient van tevoren niet of hij in de interventiegroep of de controlegroep terecht zal komen (blindering) en wordt dit ‘blind’ toegewezen (concealed allocation). Patient, behandelend arts en degene die het resultaat van de behandeling beoordeelt, blijven idealiter ook gedurende het hele onderzoek ...
De Jong, Jip, Van Dijk, Nynke
openaire +1 more source
Spotlight on Randomised Controlled Trials
Nursing in Critical Care, 2022Lyvonne N, Tume, Josef, Trapani
openaire +2 more sources
The Evolution of Randomised Control Trials.
Irish medical journal, 2016t is estimated that one third of therapies are useless. The difficulty is determining which third. It is one of the major legacy issues, from a previous era, facing modern medicine. Poor quality medical treatment is costly but more importantly it is potentially harmful.
openaire +2 more sources
An update on randomised controlled trials
Journal of Hand Surgery (European Volume), 2023openaire +2 more sources

